Reaction
Bunion Operation reporting signals
As of the last recalculation, Bunion Operation appears in 554 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is CORTISONE ACETATE (PRR 167.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cortisone Acetate | 50 | 167.2 | 167.8 |
| Diltiazem Hydrochloride Extended-Release Tablets | 28 | 97.3 | 97.6 |
| Naproxen Sodium Tablet, Coated | 29 | 84.9 | 85.0 |
| Naproxen Sodium, Coated Tablets | 29 | 84.9 | 85.0 |
| Naproxen Sodium 220Mg | 29 | 84.7 | 84.9 |
| Desoximetasone | 39 | 82.7 | 82.8 |
| Esomeprazole Magnesium Capsule, Delayed Release | 29 | 79.2 | 79.3 |
| Esomeprazole Magnesium Delayed Release Capsules | 29 | 79.2 | 79.3 |
| Esomeprazole Magnesium Dihydrate | 29 | 78.8 | 79.0 |
| Risedronate Sodium | 39 | 50.6 | 50.7 |
| Diltiazem Hydrochloride | 43 | 50.5 | 50.6 |
| Etonogestrel And Ethinyl Estradiol | 25 | 44.3 | 44.4 |
| Golimumab | 61 | 29.9 | 29.9 |
| Certolizumab Pegol | 58 | 20.7 | 20.7 |
| Abatacept | 65 | 19.8 | 19.9 |
| Lifitegrast | 3 | 6.9 | 6.9 |
| Guselkumab | 6 | 6.4 | 6.4 |